RCEL
AVITA Medical, Inc.Company Information
- Company Name
- AVITA Medical, Inc.
- CIK
- CIK0001762303
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RCEL: Nasdaq, AVHHL: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- RCEL
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-12
- Last sale
- 2023-12-26
- Shares purchased (TTM)
- 60,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,910,157
- Shares outstanding
- 30,749,894
- Ownership
- 15.97%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 117.89%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 9 | 8 | 10 | 15 | 12 | 15 | 14 | 19 | 17 | 17 | 22 | 51 | ||||||
| Marketable Securities Current | 2 | 6 | 8 | 8 | 3 | 11 | 22 | 26 | 37 | 51 | 67 | 9 | ||||||
| Accounts Receivable Net Current | 10 | 10 | 9 | 9 | 11 | 9 | 12 | 10 | 9 | 7 | 8 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 2 | 3 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| F I F O Inventory Amount | 5 | 6 | 7 | 7 | 8 | 8 | 7 | 6 | 7 | 7 | 6 | 4 | ||||||
| Assets Current | 28 | 32 | 35 | 41 | 36 | 48 | 57 | 64 | 73 | 86 | 104 | 74 | ||||||
| Property Plant And Equipment Net | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 9 | 7 | 4 | 2 | 2 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 2 | 3 | ||||||
| Intangible Assets Net Excluding Goodwill | 5 | 5 | 6 | 5 | 5 | 5 | 6 | 1 | 1 | 1 | 0 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Assets | 48 | 52 | 56 | 64 | 58 | 70 | 80 | 81 | 88 | 97 | 112 | 81 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 6 | 7 | 9 | 8 | 7 | 9 | 6 | 4 | 4 | 4 | 4 | 3 | ||||||
| Long Term Debt Current | 47 | 46 | 43 | 42 | - | - | 0 | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 3 | 3 | - | 3 | 3 | 3 | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 3 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 69 | 67 | 63 | 62 | 63 | 23 | 20 | 17 | 14 | 12 | 13 | 12 | ||||||
| Long Term Debt Noncurrent | - | - | 0 | 0 | 42 | 41 | 42 | 43 | 41 | 41 | 40 | - | ||||||
| Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Asset Acquisition Contingent Consideration Liability | 0 | 0 | 3 | 0 | 0 | 0 | 3 | - | - | - | - | - | ||||||
| Liabilities | 76 | 75 | 73 | 70 | 71 | 74 | 75 | 69 | 64 | 64 | 62 | 17 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 400 | 396 | 394 | 393 | 374 | 371 | 368 | 364 | 359 | 353 | 350 | 347 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 1 | -1 | -1 | -2 | -0 | -2 | -2 | -2 | -3 | -2 | 8 | ||||||
| Retained Earnings Accumulated Deficit | -427 | -419 | -408 | -397 | -384 | -374 | -360 | -348 | -332 | -317 | -298 | -291 | ||||||
| Stockholders Equity | -28 | -23 | -17 | -7 | -13 | -5 | 4 | 12 | 24 | 33 | 49 | 63 | ||||||
| Liabilities And Stockholders Equity | 48 | 52 | 56 | 64 | 58 | 70 | 80 | 81 | 88 | 97 | 112 | 81 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 31 | 31 | 31 | 30 | 27 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | ||||||
| Shares Outstanding | 31 | 31 | 31 | 30 | 27 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAVITA Medical, Inc. (RCEL) — SEC Financial Statements & Analysis
AVITA Medical, Inc. (RCEL) is a surgical & medical instruments & apparatus company, incorporated in DE. AVITA Medical, Inc. trades on Nasdaq, OTC as: RCEL, AVHHL. AVITA Medical, Inc. (RCEL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, AVITA Medical, Inc. carries a market cap of $127.00M, a P/E ratio of -2.95x, a P/B ratio of -4.56x, a P/S ratio of 1.70x, an enterprise value of $164.52M, and an EV/EBITDA multiple of -5.03x. On profitability, it posts a gross margin of 82.37%, an operating margin of -47.03%, a net margin of -57.53%, a Return on Equity (ROE) of 211.55%, a Return on Assets (ROA) of -81.36%, and a Return on Invested Capital (ROIC) of -236.47%. Per share, it reports EPS of $-1.40, diluted EPS of $-1.40, free cash flow per share of $-0.84, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 0.98% year-over-year, net income growth of -16.46% year-over-year, and EPS growth of -28.37% year-over-year. On the balance sheet, it maintains a current ratio of 0.41x, a quick ratio of 0.38x, working capital of $-40.32M, a debt-to-equity ratio of -2.72x, a debt ratio of 1.58, an interest coverage ratio of -6.51x, free cash flow of $-25.96M (TTM), and net debt of $37.52M. Figures sourced from SEC EDGAR.
- Market Cap
- $127.00M
- P/E TTM
- -2.95x
- EPS TTM
- $-1.40
- P/B TTM
- -4.56x
- ROE TTM
- 211.55%
- ROA TTM
- -81.36%
- Debt To Equity
- -2.72x
- Free Cash Flow TTM
- $-25.96M
- Net Revenue TTM Growth 1Y
- 0.98%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AVITA Medical, Inc. in?
AVITA Medical, Inc. (RCEL) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does RCEL trade on?
AVITA Medical, Inc. (RCEL) trades on the Nasdaq, OTC.
Where is AVITA Medical, Inc. incorporated?
AVITA Medical, Inc. is incorporated in DE.
When was AVITA Medical, Inc. (RCEL)'s most recent SEC filing?
AVITA Medical, Inc. (RCEL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is RCEL's market cap?
AVITA Medical, Inc. (RCEL) has a market capitalization of $127.00M as of 2026-06-30.
What is RCEL's EPS (earnings per share)?
AVITA Medical, Inc. (RCEL)'s trailing twelve month EPS is $-1.40 as of 2026-06-30.
What is RCEL's ROE (return on equity)?
AVITA Medical, Inc. (RCEL)'s trailing twelve month Return on Equity (ROE) is 211.55% as of 2026-06-30.
What is RCEL's ROA (return on assets)?
AVITA Medical, Inc. (RCEL)'s trailing twelve month Return on Assets (ROA) is -81.36% as of 2026-06-30.
What is RCEL's ROIC (return on invested capital)?
AVITA Medical, Inc. (RCEL)'s trailing twelve month Return on Invested Capital (ROIC) is -236.47% as of 2026-06-30.
What is RCEL's EV/EBITDA?
AVITA Medical, Inc. (RCEL)'s trailing twelve month EV/EBITDA is -5.03x as of 2026-06-30.